THALAMIC STROKE

THALAMIC STROKE was reported 67 times

These drug classes are most commonly taken by patients reporting THALAMIC STROKE:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 12
1 5-alpha Reductase Inhibitor [EPC] 11
2 Platelet Aggregation Inhibitor [EPC] 9
3 Tumor Necrosis Factor Blocker [EPC] 6
4 HMG-CoA Reductase Inhibitor [EPC] 5
5 Antimetabolite Immunosuppressant [EPC] 4
6 CD20-directed Cytolytic Antibody [EPC] 3
7 GLP-1 Receptor Agonist [EPC] 3
8 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 3
9 P2Y12 Platelet Inhibitor [EPC] 3
10 Vascular Endothelial Growth Factor Inhibitor [EPC] 3
11 Benzodiazepine [EPC] 2
12 Central Nervous System Stimulant [EPC] 2
13 Corticosteroid [EPC] 2
14 Estrogen [EPC] 2
15 Factor Xa Inhibitor [EPC] 2
16 Human Immunoglobulin G [EPC] 2
17 Interferon beta [EPC] 2
18 Janus Kinase Inhibitor [EPC] 2
19 Kinase Inhibitor [EPC] 2
20 Opioid Agonist [EPC] 2
21 Thiazide Diuretic [EPC] 2
22 Aldosterone Antagonist [EPC] 1
23 Amyloid Beta-directed Antibody [EPC] 1
24 Androgen Receptor Inhibitor [EPC] 1
25 Angiotensin 2 Receptor Blocker [EPC] 1
26 Angiotensin Converting Enzyme Inhibitor [EPC] 1
27 Aromatase Inhibitor [EPC] 1
28 Atypical Antipsychotic [EPC] 1
29 Calcitonin Gene-related Peptide Receptor Antagonist [EPC] 1
30 Calcium Channel Blocker [EPC] 1
31 Dihydropyridine Calcium Channel Blocker [EPC] 1
32 Expectorant [EPC] 1
33 GLP-2 Analog [EPC] 1
34 Glycopeptide Antibacterial [EPC] 1
35 Histamine-2 Receptor Antagonist [EPC] 1
36 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1
37 Interleukin-17A Antagonist [EPC] 1
38 Interleukin-23 Antagonist [EPC] 1
39 Lipopeptide Antibacterial [EPC] 1
40 Loop Diuretic [EPC] 1
41 Platinum-based Drug [EPC] 1
42 Programmed Death Ligand-1 Blocker [EPC] 1
43 Prostaglandin Analog [EPC] 1
44 Proton Pump Inhibitor [EPC] 1
45 Provitamin D2 Compound [EPC] 1
46 Serotonin-3 Receptor Antagonist [EPC] 1
47 Vitamin B12 [EPC] 1
48 Vitamin C [EPC] 1
49 Vitamin D [EPC] 1
50 beta-Adrenergic Blocker [EPC] 1